Abbott 4Q Revenues: $7.2 billion (+16%) 4Q Earnings: $1.2 billion (loss of $476 million 4Q06)* FY Revenues: $25.9 billion (+15%) FY Earnings: $3.6 billion (+110%) Comments: Worldwide pharmaceutical sales in the quarter were $4.2 billion, up 19%. U.S. pharma sales increased 17% and international sales were up 21%, driven by Humira, Kaletra and TriCor, as well as Niaspan sales of $179 million. Humira sales in 4Q07 and FY07 were $954 million (+54%) and $3 billion (+50%), respectively...